Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exemestane effects on visual evoked potentials in breast cancer
IRCT20250314065067N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of exemestane in breast cancer (2 arms), sponsored by Islamic Azad University. Primary endpoint: Wave amplitude. Started Mar 2026; status: completed.
02
Drugs
exemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on IRCT20250314065067N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250314065067N1.